A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma.

Jie Jin Hong Cen Ke-Shu Zhou Xiaohong Xu Fei Li Tao Wu Haiyan Yang Zhen Wang Zhi-Ming Li Wenyang Huang Hanying Bao Zusheng Xu Lugui Qiu

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)

With the very promising clinical activity against r/r PTCL, the results of this study support the further investigation of linperlisib for the treatment of r/r PTCL.

Keyphrases

multiple myeloma
hodgkin lymphoma